FDA issued recall of losartan potassium 25 mg, 50 mg and 100 mg tablets by Vivimed Life Sciences due to trace amounts of n-nitroso-n-methyl-4-aminobutyric acid (NMBA) impurity.
More on the FDA website:
www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/vivimed-life-sciences-pvt-ltd-issues-voluntary-nationwide-recall-losartan-potassium-25-mg-50-mg-and